Safety and Pharmacokinetics of Single Doses of (+)-Calanolide A, a Novel, Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy, Human Immunodeficiency Vi...

Por Creagh, Terri, Ruckle, Jon L., Tolbert, Dwain T., Giltner, Jeremy, Eiznhamer, David A., Dutta, Bipul, Flavin, Michael T., Xu, Ze-Qi
Publicado em 2001

First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain

Por Walicke, Patricia A., Hefti, Franz, Bales, Roxanne, Lu, Shiao-Ping, Ruckle, Jon L., Brown, Mark T., West, Christine R., Shelton, David L.
Publicado no Pain Rep (2018)

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males

Por Herman, Gary A, Mistry, Goutam C, Yi, Bingming, Bergman, Arthur J, Wang, Amy Q, Zeng, Wei, Chen, Li, Snyder, Karen, Ruckle, Jon L, Larson, Patrick J, Davies, Michael J, Langdon, Ronald B, Gottesdiener, Keith M, Wagner, John A
Publicado em 2011

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

Por Chinsangaram, Jarasvech, Honeychurch, Kady M., Tyavanagimatt, Shanthakumar R., Leeds, Janet M., Bolken, Tove' C., Jones, Kevin F., Jordan, Robert, Marbury, Thomas, Ruckle, Jon, Mee-Lee, Denis, Ross, Eric, Lichtenstein, Israel, Pickens, Margaret, Corrado, Michael, Clarke, Jean M., Frimm, Annie M., Hruby, Dennis E.
Publicado em 2012